Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation

被引:0
|
作者
Colunga-Pedraza, Perla R. [1 ]
Irabien-Zuniga, Mariela [1 ]
Rodriguez-Roque, Carlos Saul [1 ]
Cruz, Carlos de la Cruz-de la [1 ]
Leon, Andres Gomez-De [1 ]
Santana-Hernandez, Paola [1 ]
Jaime-Perez, Jose Carlos [1 ]
Mancias-Guerra, Consuelo [1 ]
Gomez-Almaguer, David [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Francisco I Madero Ave, Mitras Ctr, Monterrey, Nuevo Leon, Mexico
关键词
Stem cells; Autologous transplantation; Hematopoietic stem cell mobilization; Lactate dehydrogenase; COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD; G-CSF; YIELD; ISOENZYMES; AGE;
D O I
10.1016/j.htct.2022.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Pre-apheresis peripheral blood CD34+ cell count (PBCD34+) is the most important predictor of good cell mobilization before hematopoietic stem cell transplantation, albeit flow cytometry is not always immediately available. Identification of surrogate markers can be useful. The CD34+ cells proliferate after mobilization, resulting in elevated lactate dehydrogenase (LDH) activity and correlating with the PBCD34+ count.Objective: To determine the LDH cut-off value at which adequate CD34+ cell mobilization is achieved and its diagnostic yield. Materials and methods: A total of 103 patients who received an autologous stem cell transplantation (ASCT) between January 2015 and January 2020 were included. Demographic and laboratory characteristics were obtained, including complete blood count, pre-apheresis PBCD34+ and LDH levels. Receiver operating characteristic (ROC) curves were performed to identify the optimal serum LDH activity cut-off points for > 2 and >= 4 x 10(6) cells/kg post mobilization CD34+ count and their diagnostic yield.Results: A post-mobilization serum LDH cut-off value of 462 U/L yielded a sensitivity (Se) = 86.8% (positive predictive value [PPV] = 72.7%), a pre-and post-mobilization serum LDH difference cut-off value of 387 U/L, an Se = 45.7% (PPV = 97%) and an LDH ratio of 2.46, with an Se = 47.1% (PPV = 97%) for an optimal mobilization count (CD34+ >= 4 x 10(6)).Conclusion: The LDH measurement represents a fast and affordable way to predict PBCD34+ mobilization in cases where flow cytometry is not immediately available. According to the LDH diagnostic yield, it could be used as a surrogate marker in transplant centers, supporting the CD34+ count, which remains the gold standard.(c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [1] Factors Affecting Stem Cell Mobilization for Autologous Hematopoietic Stem Cell Transplantation
    Ozkurt, Zubeyde Nur
    Yegin, Zeynep Arzu
    Suyani, Elif
    Aki, Sahika Zeynep
    Acar, Kadir
    Yagci, Munci
    Sucak, Gulsan Turkoz
    JOURNAL OF CLINICAL APHERESIS, 2010, 25 (05) : 280 - 286
  • [2] Plerixafor improves mobilization autologous hematopoietic in stem cell transplantation
    Walter, Monika
    ONKOLOGIE, 2010, 33 (10): : 560 - 563
  • [3] MEXICAN BIOSIMILAR FILGRASTIM FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL MOBILIZATION AND TRANSPLANTATION
    Leon-Gonzalez, Monica
    Leon-Pena, Andres A.
    Fernanda Vallejo-Villalobos, Maria
    Karen Nunez-Cortes, Ana
    Ruiz-Arguelles, Alejandro
    Ruiz-Arguelles, Guillermo J.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2016, 68 (04): : 181 - 183
  • [4] Mobilization of Hematopoietic Stem Cells for Use in Autologous Transplantation
    Devine, Hollie
    Tierney, D. Kathryn
    Schmit-Pokorny, Kim
    McDermott, Kathleen
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (02) : 212 - 222
  • [6] Outcomes of patients after mobilization failure of hematopoietic stem cells for autologous stem cell transplantation
    Santinelli-Pestana, Diego Vinicius
    Chaer, Livia Netto
    Mariano, Livia
    Otuyama, Leonardo Jun
    Medrone Junior, Alfredo
    Rocha, Vanderson
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (03) : 256 - 260
  • [7] Hematopoietic Progenitor Cell Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma in Contemporary Era
    Arora, Satyam
    Majhail, Navneet S.
    Liu, Hien
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (04): : 200 - 205
  • [8] Mobilization Success and Bariers for Autologous Hematopoietic Stem Cell Transplantation in a Constrained Resource Nation
    Acosta-Medina, Aldo A.
    Arias-Espinosa, Luis
    Villasenor-Echavarri, Rodrigo
    Choucino, Pedro
    Martinez-Quesada, Jose I.
    Armillas-Canseco, Flor M.
    Barrera-Lumbreras, Georgina
    Bourlon, Maria T.
    Bourlon, Christianne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S284 - S285
  • [9] Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
    Grzegorz Helbig
    Małgorzata Widuchowska
    Anna Koclęga
    Anna Kopińska
    Magdalena Kopeć-Mędrek
    Władysław B. Gaweł
    Adrianna Spałek
    Jakub Żak
    Iwona Grygoruk-Wiśniowska
    Robert Liwoch
    Eugeniusz Kucharz
    Mirosław Markiewicz
    Clinical Rheumatology, 2018, 37 : 1709 - 1714
  • [10] Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
    Helbig, Grzegorz
    Widuchowska, Malgorzata
    Koclega, Anna
    Kopinska, Anna
    Kopec-Medrek, Magdalena
    Gawel, Wladyslaw B.
    Spalek, Adrianna
    Zak, Jakub
    Grygoruk-Wisniowska, Iwona
    Liwoch, Robert
    Kucharz, Eugeniusz
    Markiewicz, Miroslaw
    CLINICAL RHEUMATOLOGY, 2018, 37 (06) : 1709 - 1714